Scinai Immunotherapeutics SCNI Q4 2023 Earnings NarrowerThanExpected Loss Amid Operational Adjustments AIP Q1 2026 Earnings EPS Beats Estimates Stock Inches Higher KURA Q1 2026 Earnings ClinicalStage Biotech Misses EPS Estimates as Pipeline Development Intensifies Gladstone Investment Corporation Q1 2026 Earnings Mixed Quarter as EPS Misses Estimates Notes Edge Higher RERE Q1 2026 Earnings EPS Surges 712 Above Estimates Stock Declines on Lack of Revenue Details LOW Q1 2026 Earnings EPS Beats Estimates Amid Challenging Macro Environment